Difficult Intubation
Conditions
Keywords
fiberoptic, supraglottic, Laryngeal Tube, intubation
Brief summary
The intubating Laryngeal Tube Suction-Disposable is a new version of the Laryngeal Tube-Suction. It has a ventilator channel with a 13.5mm internal diameter, which enables the passage of an Endotracheal Tube with fiberoptic guidance. This study was designed to assess the Time fiberoptic endotracheal intubation using iLTS-D, in comparison with the and Ambu® AuraGain™ in adult patients.
Detailed description
The intubating Laryngeal Tube Suction-Disposable is a new version of the Laryngeal Tube-Suction. It has a ventilator channel with a 13.5mm internal diameter, which enables the passage of an Endotracheal Tube with fiberoptic guidance. This study was designed to assess the Time of fiberoptic endotracheal intubation using iLTS-D, in comparison with the and Ambu® AuraGain™ in adult patients. Detailed Description: The intubating Laryngeal Tube Suction-Disposable (iLTS-D) (VBM Medizintechnik GmbH, Sulz, Germany) is a new updated version of the Laryngeal Tube-Suction Disposable (LTS-D) It has a ventilator channel with a 13.5mm internal diameter, which enables the passage of an Endotracheal Tube (ETT) with fiberoptic guidance. Similarly as in to the LTS-D, the iLTS-D also has a separate channel for the purpose of placement of gastric tubes placement up to a size of 18 Fr. The iLTS-D comes in one size. According to the depth of insertion, this device is equivalent to size 4 for patients height 175 to 190 cm tall, or size 5 for patients taller than 190 cm. The iLTS-D is provided by the manufacturer with a compatible 7.5 mm ETT and with a plastic stabilizer for removal of the device. The current randomized study was designed to assess the success rate fiberoptic endotracheal intubation using iLTS-D, in comparison with the and Ambu® AuraGain™ in adult patients under general anesthesia
Interventions
Intubating Laryngeal Tube Suction
Ambu AuraGain Laryngeal Mask
Sponsors
Bnai Zion Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* American Society Anesthesiology I and II
Exclusion criteria
* Difficult intubation * Cervical pathology * pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to perform fiberoptic intubation through supraglottic device in second | 120 seconds | Time to perform endotracheal fiberoptic intubation through supraglottic device in second |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Success to obtain fiberoptic intubation through supraglottic device in second | 120 seconds | Success to obtain endotracheal fiberoptic intubation through supraglottic device in second |
Countries
Israel
Outcome results
None listed